Job Description
Title: Consultant NICU
Company Name: Bangladesh Neonatal Hospital Ltd.
Vacancy: 2
Location: Narayanganj
Salary: Negotiable
Experience:
∎ At least 1 year
∎ The applicants should have experience in the following business area(s):Hospital
Published: 26 Feb 2024
Requirements:
Responsibilities & Context:
∎ FCPS (Neonatology)/ MD/ DCH
∎ At least 1 year of working experience in NICU will be prioritized.
∎ Opportunity to work with one of the most experienced neonatalogists in Bangladesh - Dr. Md. Mozibur Rahman (Muzib), FCPS (Neonatology).
∎ Opportunity to work in the largest NICU hospital, first ever in Bangladesh even in the world.
∎ Opportunity to work in a thriving environment and workplace to ensure professional growth over time.
∎ Monitoring Patients in NICU.
∎ Monitoring activities of the Duty Doctors.
∎ Qualification Required:
∎ FCPS (Neonatology)/ MD/ DCH
∎ At least 1 year of working experience in NICU will be prioritized.
∎ Job Profile:
∎ Opportunity to work with one of the most experienced neonatalogists in Bangladesh - Dr. Md. Mozibur Rahman (Muzib), FCPS (Neonatology).
∎ Opportunity to work in the largest NICU hospital, first ever in Bangladesh even in the world.
∎ Opportunity to work in a thriving environment and workplace to ensure professional growth over time.
∎ Job Responsibilities:
∎ Monitoring Patients in NICU.
∎ Monitoring activities of the Duty Doctors.
Skills & Expertise:
Workplace:
∎ Work at office
Employment Status: Full Time
Job Location: Narayanganj
Job Highlights:
∎ Attractive honorarium.
∎ Flexible and friendly work environment.
∎ Attractive honorarium.
∎ Flexible and friendly work environment.
Company Information:
∎ Bangladesh Neonatal Hospital Ltd.
∎ Hospital Tower, Block-E, House No- E 206/1, Sahebpara, (Mijmiji), Signboard Moor, Siddhirganj, Narayanganj.
Address::
∎ Hospital Tower, Block-E, House No- E 206/1, Sahebpara, (Mijmiji), Signboard Moor, Siddhirganj, Narayanganj.
Read Before Apply: Please apply only who are fulfilling all the requirements of this job
Application Deadline: 10 Mar 2024
Category: Medical/Pharma
